Doctor profile · Federal record
Dr. Mark Malyak, MD
Rheumatology Physician · Denver, CO
- NPI 1659365211
- MIPS 89.3 / 100 · 2023
- 21 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2821 E Cedar Ave Apt 4
Denver, CO 802093397
(303) 781-4198 - Additional location
-
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
(303) 394-2828
fax (303) 320-0242 - Mailing address
-
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- January 22, 2024
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Colorado #31151
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659365211. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
91,787
Distinct HCPCS
10
Medicare allowed
$1,549,232
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 61,320 | 15 | $6 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14,550 | 33 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 6,410 | 21 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 6,240 | 64 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 754 | 331 | $91 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 539 | 84 | $137 | |
J7050 |
Infusion, normal saline solution, 250 cc | 374 | 73 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 344 | 95 | $8 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 170 | 30 | $29 | |
J1740 |
Injection, ibandronate sodium, 1 mg | 168 | 22 | $28 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 2,043. This provider delivers 45× the peer median.Open Payments
Industry payments received
All-time total
$17
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 1 | $17.01 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,558
Patients
425
Total drug cost
$1,125,823
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 308 | 110 | $5,305 |
| Hydroxychloroquine Sulfate | Generic | 292 | 88 | $23,246 |
| Tramadol Hcl | Generic | 191 | 58 | $1,407 |
| Methotrexate (Methotrexate Sodium) | Brand | 163 | 42 | $6,148 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 97 | 23 | $5,214 |
| Leflunomide | Generic | 76 | 19 | $5,609 |
| Sulfasalazine | Generic | 71 | 12 | $2,062 |
| Folic Acid | Generic | 61 | 16 | $351 |
| Enbrel Sureclick (Etanercept) | Brand | 59 | 0 | $451,786 |
| Alendronate Sodium | Generic | 48 | 14 | $476 |
Frequently asked questions
What is Dr. Mark Malyak's medical specialty?
Dr. Mark Malyak practices Rheumatology Physician in Denver, CO.
Where does Dr. Mark Malyak practice?
Dr. Mark Malyak practices at 2821 E Cedar Ave Apt 4, Denver, CO 802093397. Office phone: 3037814198.
What is Dr. Mark Malyak's NPI?
Dr. Mark Malyak's National Provider Identifier (NPI) is 1659365211, issued by NPPES.
What procedures does Dr. Mark Malyak commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.